Interpace Biosciences/ US46062X3035 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
09/05
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
GlobeNewswire
07/03
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business...
GlobeNewswire
08/11/2023
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
GlobeNewswire
29/01/2022
Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of i...
GlobeNewswire
27/01/2022
Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New Director
GlobeNewswire
12/01/2022
Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights Offering
GlobeNewswire
03/01/2022
Interpace Biosciences Announces Record Date for Proposed Fully Back-Stopped $30 Million Rights Offer...
GlobeNewswire
10/11/2021
Interpace Biosciences Announces Third Quarter 2021 Financial and Business Results
GlobeNewswire
02/11/2021
Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repaymen...
GlobeNewswire
28/10/2021
Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genot...
GlobeNewswire
21/10/2021
Interpace Diagnostics Announces US Patent Approval for Patent Application No. 11,118, 231 B2 Titled:...
GlobeNewswire
15/10/2021
Interpace Biosciences Announces New $7.5 Million Credit Facility with Comerica Bank
GlobeNewswire
10/08/2021
Interpace Biosciences Announces Second Quarter 2021 Financial and Business Results
GlobeNewswire
17/05/2021
Interpace Pharma Solutions Announces New Capability in Spatial Biology/Precision Oncology Services
GlobeNewswire
11/05/2021
Interpace Biosciences Announces First Quarter 2021 Financial and Business Results
GlobeNewswire
03/05/2021
Interpace Biosciences Announces Improved Coverage for ThyGeNEXT® and ThyraMIR®
GlobeNewswire
23/04/2021
Delisting of Securities of Interpace Biosciences, Inc., Francesca's Holdings Corporation, and Wins F...
GlobeNewswire
22/04/2021
Interpace Biosciences to Explore Strategic Alternatives for Maximizing Shareholder Value
GlobeNewswire
12/04/2021
Interpace Pharma Solutions Announces New Advanced Offering in RNA Biomarker Analysis
GlobeNewswire
05/04/2021
Interpace Biosciences Announces New PLA Code and Medicare Reimbursement Increase for Proprietary Thy...
GlobeNewswire
31/03/2021
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business Results
GlobeNewswire
17/03/2021
Interpace Biosciences Announces Divestiture of New Haven CLIA lab to DiamiR
GlobeNewswire
09/03/2021
Interpace Biosciences and XIFIN Forge Strategic Partnership to Improve Financial Performance
GlobeNewswire
25/02/2021
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of Illinois